Anti-HTN drugs have distinct effect on central, brachial SBP
(HealthDay) -- A reduction in central to brachial amplification induced by some antihypertensive drugs may result in lesser reductions in central than brachial systolic blood pressure, according to research ...
Medical research
Jun 06, 2012 |
not rated yet |
0
Scientists hunt ways to stall Alzheimer's earlier
(AP) -- Look for a fundamental shift in how scientists hunt ways to ward off the devastation of Alzheimer's disease - by testing possible therapies in people who don't yet show many symptoms, before too much ...
Alzheimer's disease & dementia
May 16, 2012 |
not rated yet |
0
FDA advisers recommend approving weight loss drug
(AP) -- Advisers to government health regulators on Thursday recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over ...
Medications
May 10, 2012 |
1 / 5 (1) |
0
EU approves Novartis drug Signifor for Cushing's disease
European Union regulators have given Swiss pharmaceutical group Novartis a green light to market its drug Signifor as a treatment for Cushing's disease, the company said Wednesday.
Medications
Apr 25, 2012 |
5 / 5 (1) |
0
Drug approved to treat high blood pressure
(HealthDay) -- The high blood pressure drug Toprol XL has been combined with a low-dose diuretic to form Dutoprol (metoprolol succinate extended release/hyrdrochlorothiazide), which has been approved by the U.S. Food and ...
Medications
Apr 13, 2012 |
not rated yet |
0
Omontys approved for anemic people with kidney disease
(HealthDay) -- Omontys (peginesatide) has been approved by the U.S. Food and Drug Administration to treat anemia in adults who require dialysis due to chronic kidney disease.
Diseases, Conditions, Syndromes
Mar 27, 2012 |
not rated yet |
0
FDA panel backs Glaxo drug for rare sarcoma cancer
(AP) -- A panel of cancer experts overwhelmingly backed the approval of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options for patients.
Cancer
Mar 20, 2012 |
not rated yet |
0
FDA weighs over-the-counter switch for key drugs
Some of the most widely used prescription drugs, including those to treat cholesterol and high blood pressure, could be available over the counter under a new proposal being weighed by government regulators.
Medications
Mar 08, 2012 |
not rated yet |
0
Review: Blood pressure drug effective for treating PTSD-related nightmares
Mayo Clinic researchers this week will announce the use of the blood pressure drug prazosin as an effective treatment to curb post- traumatic stress disorder (PTSD)-related nightmares.
Psychology & Psychiatry
Mar 06, 2012 |
5 / 5 (2) |
0
New class of potential drugs inhibits inflammation in brain
Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases.
Neuroscience
Feb 14, 2012 |
4.5 / 5 (4) |
0
|
Heart hormone helps shape fat metabolism
It's well known that exercising reduces body weight because it draws on fat stores that muscle can burn as fuel. But a new study at Sanford-Burnham Medical Research Institute (Sanford-Burnham) suggests that ...
Medical research
Feb 06, 2012 |
5 / 5 (3) |
0
|
Multiple medicines may double fall rate for young and middle aged
(Medical Xpress) -- Working-age adults who take combinations of prescription medication may be doubling their risk of serious falls at home according to research from The University of Auckland.
Medications
Jan 23, 2012 |
not rated yet |
0
First detailed data of risk of using Rasilez with certain blood pressure-lowering drugs
Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.
Medications
Jan 12, 2012 |
not rated yet |
0
Avastin disappoints against ovarian cancer
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their ...
Cancer
Dec 28, 2011 |
4.3 / 5 (4) |
1
Tireless research reveals secrets of the 'sleep hormone'
A team from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University has made a major breakthrough by unraveling the inner workings of melatonin, also known as the "sleep hormone." The ...
Neuroscience
Dec 13, 2011 |
5 / 5 (4) |
0
|
